BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9

• Press Releases

  T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors

  March 3, 2026

   · 

  3 min read
• Press Releases

  VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

  March 3, 2026

   · 

  5 min read
• Press Releases

  Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

  March 3, 2026

   · 

  8 min read
• Press Releases

  Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis

  March 3, 2026

   · 

  4 min read
• Press Releases

  Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

  March 3, 2026

   · 

  2 min read
• Press Releases

  Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026

  March 3, 2026

   · 

  1 min read
• Press Releases

  Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

  March 3, 2026

   · 

  12 min read
• Press Releases

  Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis

  March 3, 2026

   · 

  6 min read
• Press Releases

  Kyverna Therapeutics to Participate in Upcoming March 2026 Investor Conferences

  March 3, 2026

   · 

  1 min read
• Press Releases

  Opus Genetics to Present at Upcoming Investor Conferences in March 2026

  March 3, 2026

   · 

  1 min read